英派斯: 2025年半年度报告摘要

Core Viewpoint - Qingdao Impulse Health Technology Co., Ltd. reported a slight increase in revenue but a significant decline in net profit for the first half of 2025 compared to the same period last year [1]. Financial Performance - Operating revenue for the reporting period was approximately 574.49 million yuan, a 0.47% increase from 571.83 million yuan in the same period last year [1]. - Net profit attributable to shareholders was approximately 31.67 million yuan, representing a 38.09% decrease from 51.16 million yuan year-on-year [1]. - The net profit after deducting non-recurring gains and losses was approximately 28.73 million yuan, down 40.46% from 48.26 million yuan in the previous year [1]. - The net cash flow from operating activities was approximately 51.82 million yuan, an increase of 89.22% compared to 27.39 million yuan in the same period last year [1]. - Basic and diluted earnings per share were both 0.22 yuan, a decrease of 45.00% from 0.40 yuan [1]. Asset and Equity Position - Total assets at the end of the reporting period were approximately 2.86 billion yuan, a decrease of 3.01% from 2.95 billion yuan at the end of the previous year [2]. - Net assets attributable to shareholders were approximately 1.72 billion yuan, reflecting a 1.22% increase from 1.70 billion yuan at the end of the previous year [2]. Shareholder Information - The largest shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., holds 27.51% of the shares, amounting to 40.66 million shares, with some shares pledged [2]. - Other significant shareholders include Anhui Jingxi Private Fund Management Co., Ltd. and Shenzhen Hanqing Technology Co., Ltd., holding 2.44% and 1.09% of shares, respectively [3]. Important Matters - There were no changes in the controlling shareholder or actual controller during the reporting period [4].